Centre Mandates QR Codes on Critical Drugs to Block Counterfeits

The Indian Central Government has initiated a mandatory track-and-trace system using barcodes and QR codes for specific categories of critical medicines. This policy mandate is designed to combat the growing issue of counterfeit and substandard pharmaceuticals circulating within the domestic market. By requiring scannable identification on packaging, the government enables patients, pharmacists, and healthcare providers to verify the authenticity of critical drugs within seconds, ensuring that supply chains maintain higher safety standards.

Complementing the QR code initiative, the government has amended the Drugs Rules, 1945, to tighten regulations on drug formulations containing high alcohol concentrations. These specific products now require formal licensing and must be dispensed only under a valid prescription, complying with Schedule H1 guidelines. This regulatory shift aims to curb the misuse of medicinal products with significant alcohol content, reflecting a broader effort by health authorities to standardize and monitor high-risk pharmaceutical manufacturing and distribution processes.

These twin measures underscore the government's commitment to enhancing national health security by professionalizing drug handling and verification. Industry experts anticipate that these changes will pressure manufacturers to adopt more rigorous quality control protocols and digital tracking systems to remain compliant. As these rules take effect, they are expected to significantly reduce the risk of patients inadvertently consuming fake drugs while fostering a more transparent and regulated pharmaceutical retail environment across India.